Regenerative Medicine in the UK Health System: Challenges, Prospects and Readiness
23 May 2017, Anatomy Lecture Theatre, Kings College London
This conference reports on the findings of a major three-year ESRC research project on regenerative medicine. It is the first of its kind in providing a social science perspective on the development, current situation and likely future of the field within the wider NHS context.
The conference will be of value to different audiences interested in a detailed, ground-breaking analysis of the area: those working in innovation policy, commissioning, and technology evaluation in the health service, academic social scientists exploring the dynamics of emergent biomedical sciences, clinicians and biomedical scientists, healthcare professionals, patient groups, regulatory experts, and those in Parliament with responsibility for policy relating to health, science and technology. As such, the meeting provides an excellent opportunity to meet different actors in the field, and create new links for future engagement. The meeting will be strongly interactive, structured around panels, open discussion and poster presentations.
The findings will contribute to policy and national thinking. The meeting, to be chaired by Professor Andrew Webster (PI) brings together the research team from York, Birmingham, Edinburgh and Sussex, as well as expert practitioners from the project’s Advisory Group and various stakeholders who have played a vital role in ensuring the research addressed current issues of concern, notably how to translate this emergent field into the clinic.
The conference will provide an opportunity to discuss stakeholders’ views in particular on health service readiness – or ‘institutional readiness’ - for regenerative medicine.
The conference speakers are drawn from the project team and the Advisory Group as well as guest speakers from the UK, US and Europe.
A full conference programme will be available shortly.
Lunch plus a closing wine reception will be provided for all registered delegates.
Registration: There is no fee for the conference, but all delegates will need to register in advance (see link below). Registration is open until 31 March and there are limited places.
Register your intention to attend through the following Eventbrite link:
Meeting with the All Party Parliamentary Group
8 November, House of Commons
Members of the project and guest speaker Professor Tony Pagliuca from KCL presented the latest findings of the project to about 30 delegates including parliamentarians, researchers and senior staff from the major UK government regulatory and innovation agencies. The morning was chaired by Baroness Masham. The meeting led to a number of important outcomes in regard to various issues to be pursued with MPs. A summary of the meeting can be found here.
Meeting with the MHRA's Patient Forum
11 November, MHRA, London
Members of the project team in collaboration with the MHRA's Public Engagement Director, Mike Dykes, organised a day-long event for patient charities where the project results were presented and patient concerns explored and discussed. Some of those attending included the Alzheimer's Society, BHF. Cure Parkinson's Trust, Diabetes UK, and the genetic Alliance UK.
Among a range of issues examined were pathways to the clinic, rare diseases and orphan drugs, funding for regenerative medicine, different types of medical device and their classification, regulation and patient perspectives. A report on the meeting can be found here (PDF , 304kb).
Expert report issued on UK regenerative therapies industry A report detailing progress following the recommendations of the Regenerative Medicines Expert Group (RMEG) has been issued to George Freeman, Minister for Life Sciences. CEOs from key delivery organisations including the Cell and Gene Therapy Catapult, NHS England, NHS Blood and Transplant, Medicines and Healthcare Products Regulatory Agency, Human Tissue Authority, NICE and Human Fertilisation and Embryology Authority all contributed to the report.
It found that regenerative therapies are now beginning to show significant clinical potential and that there has been rapid expansion in the sector in the UK.
The report from the Regenerative Medicine Expert Group, which includes members from the project team, is now available from the Department of Health website.
Please use the following link:
In addition to the main report the page also provides access to a formal response, from the Minister for Life Sciences, in the form of a letter to the Chair of RMEG.
The REGenableMed project has part sponsored a film developed by our Edinburgh partners which explroes key issues relating to the field. The film was made as part of the ESRC's Festival of Social Science. See film here.
Keep up-to-date or sign up to the newsletter with all the latest on Stem Cell news here at the PHG Foundation blog
Stem cellls allow nearly blind patients to see (here)
Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies - The Lancet, 15 October 2014.